Progenics Pharmaceuticals, Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PGNX Nasdaq 8731 5.905 Stock Down -0.155

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Progenics Pharmaceuticals, Inc

8:31 am Progenics Pharm receives a $50 mln milestone payment from Valeant Pharma (VRX) resulting from the FDA's marketing approval last week of RELISTOR Tablets for the treatment of opioid-induced constipat - Jul 26th, 2016 12:31 pm